CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 61 enrolled
Drug / intervention
Smartphone app +2 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05897242
NCT05897242N/ACompleted

ACT on Vaping: Digital Therapeutic for Young Adult Vaping Cessation

Fred Hutchinson Cancer Center·interventional·Posted Jun 9, 2023·Updated Jun 24, 2025

In Brief

A clinical study evaluating Smartphone app, Text Message, and 1 other intervention for Nicotine Dependence and 4 related conditions. Completed, enrolled 61 participants across 1 site.

Detailed Summary

Almost one in ten young adults report current e-cigarette use, putting them at risk of developing nicotine addiction and long-term health effects of exposure to inhaled toxicants. Despite the need for effective treatments to help these young users quit, very few treatments targeting any type of tobacco use among young adults have been evaluated, particularly for young adults who vape and have unique treatment needs. To address these needs, this trial will evaluate a digital program for young adult e-cigarette users at all stages of readiness to quit called ACT on Vaping.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
202420252026
First PostedJun 9, 2023
Enrollment StartJan 4, 2024
Primary CompletionApr 26, 2024
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 3.1 years ago

Interventions

Smartphone appbehavioral

Use ACT on Vaping smartphone app

Text Messageother

Receive text messages

Survey Administrationother

Ancillary studies